Position in GH
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$253,250
New position
Shares Held
1,688
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#426
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 97%
Shared 0%
None 3%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Equitable Holdings, Inc. holds $13,321,050 across 7 Diagnostics & Research names. GH ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
14,295 | $7,166,941 | |
| 2 | DHR |
Danaher Corp /De/
|
15,830 | $3,015,298 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,752 | $1,448,762 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
1,482 | $784,852 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,167 | $418,707 | |
| 6 | GH |
Guardant Health, Inc.
This page
|
1,688 | $253,250 | |
| 7 | LH |
Labcorp Holdings Inc.
|
833 | $233,240 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,250 | 1,688 | Shares | Defined | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||